FMP
EURONEXT
0.974 EUR
-0.006 (-0.616%)
Mr. Enrico Bastianelli M.B.A., M.D., MBA
Healthcare
Biotechnology
https://www.thera.vet/en
EURONEXT
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.
N/A
BE0974387194
N/A
Rue d'Edimbourg 11b
N/A
BE
7
Jun 17, 2021
-
EURONEXT
Biotechnology
Healthcare
-
BE0974387194
BE
0.97
-0.27
8.8k
3.14M
-
0.82-3.5
0
-
-
-
-
-1.5
-
https://www.thera.vet/en
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.